New eye camera could diagnose problems in seconds
NCT ID NCT07218835
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a compact, handheld eye imaging device that takes pictures of the eye in seconds. Researchers want to see if it is easy to use, mobile, and reliable. The device will be tested on 70 people with eye complaints, and the images will be compared to official diagnoses from a full eye exam.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Auto-aligning ocular imaging instrument (device)
- What this could lead to
- If successful, this device could make eye exams quicker and more accessible, potentially helping diagnose eye conditions in settings without specialist equipment.
- What could go wrong
- This is an early-stage study focused on ease of use and image quality, not on treatment outcomes. The device may not match the accuracy of a full eye exam.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Duke Eye Center patients will be drawn from the Eye Center clinics and from Duke Emergency Department consulted by ophthalmologist in the Emergency Department.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Ocular complaints potentially indicating anterior segment pathology (e.g., corneal abrasions, corneal edema, corneal scars) * Ocular complaints potentially indicating posterior segment pathology (e.g., macular edema, neovascular, macular degeneration) Exclusion Criteria: * Participant is unable to be imaged for any reason
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Corneal edema are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Duke Eye Center
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One shot to see clearly: cell therapy takes on corneal edema
- New eye drug aims to restore vision in Diabetes-Related swelling
- New eye drug aims to restore vision in Diabetes-Related swelling
- Saline showdown: which eye drop clears Post-Surgery swelling faster?
- Could a 15-minute dip in your own blood save your cornea transplant?
- Lockdown diaries: 1,300 patients reveal hidden health risks